ArticleACS omega2024
A Simple and Sensitive Wearable SERS Sensor Utilizing Plasmonic-Active Gold Nanostars.
Article in ACS omega, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed.
- Cancer Drug Delivery with Nanoparticles and Biomolecules: Stimuli-Responsive, Theranostic, and AI-Guided Approaches.Materials (Basel, Switzerland) · 2026Review
- Photonic Nanomaterials for Wearable Health Solutions.Advanced materials (Deerfield Beach, Fla.) · 2025Review
- Investigation of Phosphonic Acids Based on Raman and Surface-Enhanced Raman Spectroscopy.ACS omega · 2025Article
- Three-Dimensional SERS Substrates: Architectures, Hot Spot Engineering, and Biosensing Applications.Biosensors · 2025Review
- Surface Enhanced Raman Scattering for Biomolecular Sensing in Human Healthcare Monitoring.ACS nano · 2025Review
- Trends and Advances in Wearable Plasmonic Sensors Utilizing Surface-Enhanced Raman Spectroscopy (SERS): A Comprehensive Review.Sensors (Basel, Switzerland) · 2025Review
- Towards Point-of-Care Single Biomolecule Detection Using Next Generation Portable Nanoplasmonic Biosensors: A Review.Biosensors · 2024Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Wearable sweat sensors hold great potential for offering detailed health insights by monitoring various biomarkers present in sweat, such as glucose, lactate, uric acid, and urea, in real time. However, most previously reported sensors, primarily based on electrochemical technology, are limited to monitoring only a single analyte at a given time. This study introduces a simple, sensitive, wearable patch based on surface-enhanced Raman spectroscopy (SERS), integrated with highly plasmonically active sharp-branched gold nanostars (GNS) for the simultaneous detection of three sweat biomarkers: lactate, urea, and glucose. We have fabricated the GNS on commercially available adhesive tape, resulting in achieving a low-cost, flexible, and adhesive wearable SERS patch. The limits of detection for lactate, urea, and glucose were achieved at 0.7, 0.6, and 0.7 μM, respectively, which are significantly lower than the clinically relevant concentrations of these biomarkers in sweat. We further evaluated the performance of our wearable SERS patch during outdoor activities, including sitting, walking, and running. To evaluate its overall effectiveness, we simultaneously measured the concentrations of lactate, urea, and glucose during these activities. Overall, our simple, sensitive wearable SERS sensor represents a significant breakthrough by enabling the simultaneous detection of lactate, urea, and glucose present in sweat, marking a major step toward future applications in autonomous and noninvasive personalized healthcare monitoring at home.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.